Questions About Insulin

Learn About Humalog Mealtime Insulin
separetorPrinter Friendly Version
Glossary
Longer-acting Insulin
Insulin that takes longer to work than rapid-acting insulin, but its duration of action (how long it works) can last up to 20 hours. Humalog Mix75/25 and Humalog Mix50/50 both contain longer-acting insulin to help keep blood glucose stable between meals.
Glossary
Sulfonylureas
A class of oral medicine for type 2 diabetes that lowers blood glucose. Examples include Amaryl® (glimepiride), Glucotrol® (glipizide), and Micronase® (glyburide).
Humalog is for use in people with diabetes to help control high blood sugar and should be used with a longer-acting insulin, except when used in combination with oral medication (sulfonylureas) in people with type 2 diabetes. Taken each time you eat, Humalog closely mimics the body's own insulin at mealtime, offering you convenience and flexibility. In fact, Humalog is the #1 mealtime insulin prescribed by doctors who specialize in treating diabetes.*

This section will help you learn more about Humalog, from its benefits to its use in insulin pumps. Only your doctor can know which insulin is right for you or a loved one, so be sure to take advantage of the Questions for Your Healthcare Team to discuss your individual needs. Humalog is made by Lilly, a world leader in diabetes care for more than 80 years.

Humalog is available by prescription only. See Humalog Patient Information for important facts about this product.

* Based on the National Prescription Audit from November 2004, reflecting prescriptions for mealtime insulins.






Important Safety Information
Humalog, Humalog Mix75/25, and Humalog Mix50/50 are for use in patients with diabetes to control high blood sugar. Humalog should be used with a longer-acting insulin, except when used in combination with sulfonylureas in patients with type 2 diabetes.

Humalog insulins are contraindicated during episodes of hypoglycemia and in patients sensitive to Humalog or one of its excipients. The safety and effectiveness of Humalog in patients less than 3 years of age have not been established. Safety and effectiveness of Humalog Mix75/25 and Humalog Mix50/50 in patients less than 18 years of age have not been established. There are no clinical studies of the use of Humalog insulins in pregnancy or nursing mothers.

Potential side effects associated with the use of all insulins include low blood sugar, weight gain, low blood potassium, changes in fat tissue at the site of injection, and allergic reactions, both general and local. Humalog Mix75/25 and Humalog Mix50/50 should not be mixed with another insulin. Starting or changing insulin therapy should be done cautiously and only under medical supervision.

Humalog insulins are available by prescription only. See the Humalog, Humalog Mix75/25, and Humalog Mix50/50 Patient Product Information for important facts about these products.

Humalog is a registered trademark of Eli Lilly and Company. Humalog Mix75/25 and Humalog Mix50/50 are trademarks of Eli Lilly and Company.



Humalog Patient Information | Humalog Mix75/25 Patient Information | Humalog Mix50/50 Patient Information | Important Safety Information